Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial (Q38785510)
Jump to navigation
Jump to search
scientific article published on 05 December 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial |
scientific article published on 05 December 2016 |
Statements
1 reference
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial (English)
1 reference
1 reference
1 reference
Masatoshi Kudo
1 reference
Gerold Meinhardt
1 reference
Shukui Qin
1 reference
Tianqiang Song
1 reference
Philippe Merle
1 reference
György Bodoky
1 reference
Marc Pracht
1 reference
Osamu Yokosuka
1 reference
Olivier Rosmorduc
1 reference
Valeriy Breder
1 reference
René Gerolami
1 reference
Gianluca Masi
1 reference
Paul J Ross
1 reference
Jean-Pierre Bronowicki
1 reference
Isabelle Ollivier-Hourmand
1 reference
Richard S Finn
1 reference
Marie-Aude LeBerre
1 reference
Annette Baumhauer
1 reference
Guohong Han
1 reference
RESORCE Investigators
1 reference
5 December 2016
1 reference
1 reference
389
1 reference
10064
1 reference
56-66
1 reference
Identifiers
1 reference
1 reference